SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (188)1/20/1997 5:14:00 PM
From: Larry Liebman   of 6136
 
Richard, I had a similar take...I expected AGPH to get "punished" on the downgrade...Of course, then I realized that the analyst only had AGPH as "outperform", leaving one to believe how accurate their assessment had been in the first place...AGPH C.E.O. has been making what appear to be very "bullish" statements regarding Viracept- this from a guy who I rarely see hype its' products...I watched Vertex take more of a beating...Do you know how much of the profits will accrue to VRTX?...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News